7 CONCLUSÕES
De acordo com os resultados obtidos nesse estudo pode-se concluir que:
- na cidade de São José do Rio Preto há elevada ocorrência de leveduras do gênero Cryptococcus spp em excretas de Columbiformes, Galliformes, Passeriformes e Psittaciformes;
- além de C. neoformans e C. gattii, observou-se a colonização das excretas de aves por outras espécies, como C.unigutullatus e, em maior frequência, C.
albidus e C. laurentii;
- os isolados clínicos de C. neoformans e C. gattii apresentaram altos valores de CIM para itraconazol e anfotericina B, sugerindo contato prévio com estes fármacos;
- as cepas ambientais de C. neoformans e C. gattii foram sensíveis a todos os antifúngicos;
- as espécies C. albidus e C.laurentii exibiram índices elevados de CIM para maioria das drogas antifúngicas.
REFERÊNCIAS BIBLIOGRÁFICAS
ABEGG, M.A.; CELLA,F.L.; FAGANELLO, J.; VALENTE, P.; SCHRANK, A.; VAINSTEIN, M.H. Cryptococcus neoformans and Cryptococcus gattii isolated from the excreta of Psittaciformes in the Southem Brasilian zoological garden.Mycopathologia. n. 161.v. 2, p.83-91.2006.
ALMEIDA, A.M.; MATSUMOTO, M.T.; BAEZA, L.C.; de OLIVEIRA, E.; SILVA, R.B.; KLEINER, A.A. Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from São Paulo state, Brazil. FEMS. Yeast
Res; v.7. p.152-64.2007.
ALSPAUGH, J. A.; DAVIDSON, R. C.; HEITMAN, J. Morphogenesis of Cryptococcus
neoformans. Contrib Microbiol, v. 5, p. 217-238. 2000.
ALSPAUGT J.A, PERFECT JR. Cryptococcal meningitis. Curr Treat Opin Infect
Dis; v.4,p.75–80.2002.
ANDRIOLE, V.T. History of antifungal therapy. Infect Dis Clin Pract; v.7: p. 2- 7.1998.
ANVISA. Agência Nacional de Vigilância Sanitária. Lista de Adversidades em Saúde. http://lisas.anvisa.gov.br.2006. Acesso em 15 de março de 2011.
ARAGÃO, R.E.M.; BARREIRA ,C.M.M.A.; RIBEIRO, D.C.S.; TIMÓTEO, C.N.G. Amaurose bilateral por menigoencefalite criptocócica: relato de caso Arq Bras
Oftalmol v.71. n.1 São Paulo. 2008.
AVERBUCH,D.;BOEKHOUTT,T.;FALK,R. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol.v.40,p.479-484.2002.
neoformans isolados em Sergipe no período de 2001 a 2004. Dissertação. Universidade Federal de Sergipe. 2005.
BARNETT, J. A., R. W. PAYNE and D. YARROW. Yeasts: Characteristics and Identification, 3rd ed. Cambridge University Press, Cambridge, p.1139 2000.
BICANIC, T.; HARRINSON, T. S. Cryptococcal meningitis. British Med Bulletin. v.72, n.1, p.99-118, 2004.
BICANIC, T.; HARRINSON, T. S. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazol monotherapy: the role of fluconazole resistance and immune reconstitution. Clin of Infect Dis v.43, p.1069-1073, 2005. BIVANCO, F.C.; MACHADO, C.A.S.; MARTINS, E.L. Criptococose cutânea. Arq
Med ABC; v.20,p. 102-9.2006.
BOEKHOUT, T, THEELEN, B, DIAZ, M, FELL,J, HOP, W, ABELN, E, DROMER, F, MEYER, W. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans.
Microbiol v.147,p.891–907.2001.
BRANDT, M. E., M. A. PFALLER, R. A. HAJJEH, R. J.HAMILL, P. G. PAPPAS, A. L. REINGOLD, D. RIMLAND, and D. W. WARNOCK. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother. v.45.p.3065–3069.2001.
CALVO, B.; FISCHMAN, O.; CASTELO FILHO, A.; REIS FILHO, J.; DEL BIANCO,R.; BARBOSA, R.M.; ZAROR, L. Deteccion de antigeno del polisacarido capsular de Cryptococcus neoformans em pacientes com SIDA y neurocriptococosis em São Paulo, Brasil. Rev Inst Med Trop de São Paulo, v.33, n.6,p.485-90, 1991.
CALVO,B.M.;COLOMBO,A.L.;FISCHMAN, O.; SANTIAGO,A.; THOMPSON, L.;LAZERA, M.; TELLES, F.; FUKUSHIMA, K.; NISHIMURA, K.; TANAKA, R.; MYIAJY, M.; MORETTI-BRANCHINI, M.L. Antifungal susceptibilities , varieties and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile and Venezuela. J Clin Microbiol.v. 39 (6): p.2348-2350.2001.
CASADEVALL, A.; FREUNDLICH, L.; MARSH, L.; SCHARFF, M.D. Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol.v.30.1992.
CASADEVALL A, PERFECT JR. Cryptococcus neoformans. Washington:ASM
Press, 420, 464.1998.
CASADEVALL, A.; ROSAS, A.L.; NOSANCHUK, J.D.Melanin and Virulence in
Cryptococcus neoformans.Current Opinion in Microbiology v.3,p.354-358.2000.
CASALI, A. K.; STAATS, C. C.; SCHRANK, A.; VAINSTEIN, M. H. Cryptococccus
neoformans: aspectos moleculares e epidemiológicos. Biotecnologia, Ciência e
Desenvolvimento, v.20, p.34-37, 2001.
CASALI, A.K, GOULART, L., SILVA, L.K.R Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res; v.33,p.405–15.2003.
CATALÁN, M, MONTEJO, JC. Antifúngicos sistémicos. Farmacodinamia farmacocinética. Rev Iberoam Micol; v.23,p.39-49.2006.
CDC, Center for Disease control and Prevention. Cryptococcosis. Disponível em: <http:www.cdc.gov>. Atualizado em: outubro de 2005. Acesso em 11 de novembro de 2009.
apple and brown rot of sweet cherry by natural saprophytic yeasts alone or in combination with low doses of fungicides. Biol Control.v.6,p.253-259.1996.
CHANG, Y. C.; PENOYER, L. A.; KWON-CHUNG, K. J. The second capsule gene of
cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun. v. 64,
n.6,p.1977-1983.1996.
CHARIYALERTSAK, S., SIRISANTHANA, T. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: regional variation and temporal trends. Clin Infect Dis v. 32 (6),p.955–962.2001. CHATURVEDI, S.; RODEGHIER, B.; FAN, J.. - Direct PCR of Cryptococcus
neoformans MATa and MATa pheromone to determine mating type, ploidy, and
variety: a tool for epidemiological and molecular pathogenesis studies. J Clin
Microbiol , v.38,p.2007-2009, 2000.
CHAYAKULKEEREE,M.; PERFECT,J.R. Cryptococcosis. Infect Dis Clin North
Am. v.20(3),p.507-44.2006.
CHEN, S, SORRELL, T, NIMMO, G, SPEED, B, CURRIE, B, ELLIS, D, MARRIOTT, D, PFEIFFER, T, PARR, D, BYTH, K. Epidemiology and host - variety dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 31: 499-508.2000. COLOMBO, A. L.; ALVES, S. H. Testes de susceptibilidade a antifúngicos. In: SIDRIM, J. J. C.; ROCHA, M. F. G. Micologia Médica à Luz de Autores
Contemporâneos. 1ª ed. Rio de Janeiro: Guanabara Koogan,.cap 10.p. 102-
CORREA, M.P.S.C.;OLIVEIRA, E.C.; DUARTE, R .R. B.S.; PARDAL,P.P.O.; OLIVEIRA, F.M.; SEVERO, L.C. Criptococose em crianças no estado do Pará, Brasil. Rev Soc Brás Méd Trop.v.32.p.505-508.1999.
COX,G. M.; MUKHERJEE, J.; COLE, G. T.; CASADEVALL, A.; PERFECT, J. R. Urease as a virulence factor in experimental cryptococcosis. Infect Immun., v. 68, n.2, p. 443-448. 2000.
COX, G.M. Extracellular Phospholipase activity is a virulence factor for Cryptococcus
neoformans. Mol Microbiol.v.39, n.1, p.166-75, 2001.
COX GM, HARRISON TS, McDADEHC, TABORDA CP, HEINRICH G, CASADEVALL A, PEDFECT JR. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect
Immun. v.71,p.173–180. 2003.
DANNAOUI, E.; ABDUL, M.; ARPIN, M.; MICHEL-NGUYEN, A.; PIENS, M.A.; FAVEL, A.; LORTHOLARY, O.; DROMER, F.; The French Cryptococcosis study group. Antimicrob Agents Chemother., v. 50, p. 2464-2470, 2006.
DARZÉ, C.; LUCENA, R.; GOMES, I.; MELO, A. - Características clínicas e laboratoriais de 104 casos de meningoencefalite criptocócica. Rev Soc Bras Med
Trop., v.33,p.21-26, 2000.
DEL POETA, M.; CRISTINA CRUZ, M.; CARDENAS, M.E.; PERFECT, J.R.; HEITMAN, J. Synergistic Antifungal Activities of Bafilomycin A1, Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents
Chemother., v. 44, p. 739-746, 2000.
DEL POETA, M. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell. v.3,p.1067–1075.2004.
DELGADO,A.C.N.;TAGUCHI,H.;MIKAMI,Y., MYIAJY,M.; VILLARES,M.C.B.; MORETTI,M.L. Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.
Mycopathologia .v. 159,p. 7–11.2005.
DIAMOND, R. D. Cryptococcus neoformans.. Principles and practice of infectious diseases. In: Mandell GL,Bennett JE, Dolin R (eds).Philadelphia, USA: Churchill Livingstone.p.2707-18.2000.
DIXIT, A.; CARROLL,S.F.; QURESHI,S.T. Criptococcus gattii: an emerging cause of fungal disease in North America. Interdisc Perspec on Infect Disease.2009.
ELLIS, D.H.; PFEIFFER, T.J. Natural habitat of Criptococcus neoformans var. gatii.
J. Clin. Micobiol.v.28.1990.
ESPINEL-INGROFF,A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). Rev
Iberoam Micol., v.26(1), p.15-22.2009.
EUROPEAN COMMITTEE ON ANTIMICROBIAL SUSCEPTIBILIT Y TESTING (E.Dis. 7.1) and CLSI (M27-A2) J Clin Microbiol; v.45,p. 109–11. 2007b.
FARIA, Renata Osório de et al. Occurrence of Cryptococcus neoformans in pigeon excrement in the city of Pelotas, State of Rio Grande do Sul. Rev Soc Bras Med
Trop. v.43, n.2. 2010.
FAVALESSA, O.C.; RIBEIRO, L.C.; TADANO,T.; FONTES, C.J.F.; DIAS,F.B.; COELHO, B.P.A.; HAHN, R.C. First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso. Rev Soc Bras Med Trop.v. 42(6),p.661-665, 2009. .
FELDMESSER, M., TUCKER, S. Intracellular parasitism of macrophages by
Cryptococcus neoformans. Trends Microbiol. v.9 (6), p.273–278.2001.
FERNANDES, O.F.; COSTA, T.R.; COSTA, M.R.; SOARES, A.J.; PEREIRA A.J.S.C. e SILVA, M.R.R. Cryptococcus neoformans isolados de pacientes com AIDS. Rev
Soc Bras Med Trop. v.33 n.1 Uberaba. 2000.
FERNANDES, O.F.L, PASSOS, X.S, SOUZA, L.K.H, MIRANDA, A.T.B, CERQUEIRA, C.H.P.V., SILVA, M.R.R. In vitro susceptibility characteristics of
Cryptococcus neoformansvarieties from AIDS patientes in Goiânia, Brazil. Mem Inst
Oswaldo Cruz; v.98,p.839–41. 2003.
FILIÚ, W.F.; WANKE, B.; AGÜENA, S.M.; VILELA, V.O.; MACEDO, R.C.; LAZÉRA, M. Avian habitats as sources of Cryptococcus neoformans in the city of Campo Grande, Mato Grosso do Sul (Brazil). Rev Soc Bras Med Trop.v. 35,p.591-595, 2002.
FRASER, J.A.; SUBARAN, R.L.; NICHOLS, C.B.; HEITMAN, J. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryotic Cell, v.2, n.5,p.1036-45, 2003.
FRIEDMAN,G.D.;FESSEL,W.J.;UDALTSOVA,N.V;HURVEY,L.B.Cryptococcosis the 1981–2000 epidemic. Mycoses,2005.
GANENDREN, R; CARTE, E.; SORRELL, T.; WIDMER, F.; WRIGHT, L. Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line. Microbes Infect; v.8,p.1006–15. 2006.
GATES, M. A.; THORKILDSON, P.; KOZEL, T. R. Molecular architecture of the
antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J
Clin Microbiol Infect Dis.v.25,p.138-149.2006.
GRANADOS, D.P.; CASTAÑEDA, E. Isolation and characterization of Cryptococcus
neoformans varieties recovered from natural sources in Bogotá, Colombia, and study
of ecolological conditions in the area. Microbial Ecology, v.49, p. 282-90, 2005. GUIMARÃES, A.J.; FRASES,S.; CORDERO,R.J.; NIMRICHTER,L.; CASADEVALL,A.; NOSANCHUK,J.D. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo. Cell Microbiol,v.8,p.135- 138.2010.
HAKIM, J.G., GANGAIDZO, I.T., Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS v.14 (10), p.1401–1407.2000.
HAMANN, I.D.; GILLESPIE, R.J.; FERGUSON, J.K. - Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in immunocompetent host. Aust. J
Derm., v.38,p. 29-32, 1997.
HELBOK, R., PONGPAKDEE, S. Chronic meningitis in Thailand. Neuroepidem v. 26 (1), p.37– 44.2005.
HOLMES, C.B., LOSINA, E.,. Review of human immunodeficiency virus type 1- related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. V.36 (5), p.652–662.2003.
HULL, C.M., HEITMN, J.Genetics of Cryptococcus neoformans. Annu Rev
HULL, C. M.; HEITMAN, J. Sexual reproduction between partners of the same mating type in Cryptococcus neoformans. Nature. v.21, n.434 (7036), p.1017.21. 2005.
IDNURM, A.; BAHN, Y.S.; NIELSEN, K.. - Deciphering the model pathogenic fungus
Cryptococcus neoformans. Nature Rev. Microbiol., v.3,p. 753-64, 2005.
IGREJA, R.P.; LAZERA, M.S.; WANKE, B. Molecular epidemiology of Cryptococcus
neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Med
Mycol., v.42,p.229-238, 2004.
IIINAIT-ZARAGOZI, MT, MARTÍNEZ, GF, CURFS-BREUKER, I, FERÑANDES CM, BOEKHOUT,T, MEIS, JF. In vitro activity of the new azole isavuconazole (BAL 4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother; v.52,p.1580-2. 2008.
JACOBSON, E. Pathogenic roles for fungal melanins. Clin Microbiol Rev v.13,p.708-717. 2000.
JAIN N, WICKES, BL, KELLER, SM, FU, J, CASADEVALL, A, JAIN, P, RAGAN,MA, BANERJEE, U, FRIES, BC. Molecular epidemiology of clinical Cryptococcus
neoformans strains from India. J Clin Microbiol; v.43,p. 5733-5742. 2005.
JARVIS, J.N.; HARRISON, T.S. HIV-associated cryptococcal meningitis. AIDS v.21,p.2119-2129, 2007.
JARVIS, J.N.; DROMER,F.; HARRISON,T.S.; LORTHOLARY,O. Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis. v.21(6),p.596-603.2008.
KANTARCIOGLU, A.S.;BOEKOUT, T.; DE HOOG, G.S.;THEELEN,B.; YUCEL,A.;EKMEKCI, T.R; et.al. Subcutaneous cryptococcosis due to Cryptococcus
diffluens in a patient with sporotrichoid lesions case report, features of the case
KARKOWSKA-KULETA, J.; RAPALA-KOZIC, M.; KOZIC, A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus
neoformans and Aspergillus fumigatus. Acta Bioch Polonica v.56,p.211-224, 2009.
KAWAKAMI, K. Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Japan J Infect Dis, v.57, p.137-145, 2004.
KHAN, Z. U.; AL-ALNEZI, A .A.; CHANDY, R.; XU, J.Disseminated cryptococcosis in an AIDS patient caused by canavanine-resistant strain Cryptococcus neoformans var. grubii. J Med Microbiol, v.2052,p.271-275.2003.
KHAWCHAROENPORN, T.; APISARNTHANARA,K,A.; MUNDY, L.M. Non-
neoformanscryptococal infections: a systematic review.Infection.v.35,p.51-58.2007.
KIDD,S.E.; HAGEN,F.; TSCHARKE,R.L.;HUYNH,M.;BARTLETT,K.H.; FYFE.; MacDOUGALL,L.; BOEKHOUT,T.; KWON-CHUNG,K.J.; MEYER,W. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).PNAS.2004.
KIELSTEIN,P.B.; HOTZEL,H.; SCHMALRECK,A.; KHASCHABI,D.; GLAWISCHNIG,W. Occurrence of Cryptococcus spp in excreta of pigeons and pet birds. Mycoses, v.43,p. 7–15.2000.
KNOKE, M.; SCHWESINGER, G. One hundred years ago: the history of cryptococcosis in Greifswald. Medical mycology in the nineteenth century.
Mycoses, v.37, p. 229-233, 1994.
KOBAYASHI, C. C. B. A.; HASIMOTO E SOUZA, L. K.; FERNANDES, O. F. L.; BRITO, S. C. A.; SILVA, A. C.; SOUSA, E. D.; SILVA, M. R. R. Characterization of
Cryptococcus neoformans isolated from urban environmental sources in Goiânia,
KOHNO, S. Clinical and Mycological Features of Cryptococcosis. Jpn J Med Mycol. vol 44, p.159-162.2003.
KOHNO, S.Variety in cryptococcal pathogenesis. In: the 6th International
Conference on Cryptococcus and Cryptococcosis, Boston, MA, Boston
University School of Medicine.2005.
KON, A.S.; GRUMACH, A.S.; COLOMBO, A.L.; PENALVA, A.C.O.; WANKE, B.; TELLES, F.Q.; SEVERO, L.C.; ARANHA, L.F.; LAZÉRA, M. S.; RESENDE, M.R.; SALMITO, M.A.; SHIKANAI-YASUDA, M.A.; MORETTI, M.L.; FERREIRA, M.S.; SILVA-VERGARA, M. L.; ANDRADE, M.N.P.; TRABASSO,P.; MENDES, R.P.; MARTINEZ, R.; PONZIO,V. Consenso em Criptococose. Relatório técnico. Rev Soc
Bras Med Trop v.41(5),p.524-544.2008.
KOTWANI, R. N.; GOKHALE, P. C.; BODHE, P. V.; KIRODIAN, B. G.; KSHIRSAGAR, N. A. Safety and efficacy of liposomal amphotericin B in patients with cryptococcal m eningitis. Assoc Physicians India. v.49, p.1086-90, 2001.
KUMAR, P.; SARAN, R.K.; GONDAL, R.; MALHOTRA, V. Smear morphology of cryptococcosis presenting as a subcutaneous swelling in healthy adults: a report of three cases. Cytopathol. v.16,p.143-6. 2005.
KUMARASAMY, N., VALLABHANENI, S. Clinical profile of HIV in India. Indian J
Med Res. v.121 (4), p.377–394.2005.
KURTZMAN, C.P.; J. W. FELL. The Yeasts, A Taxonomic Study, 4th ed. Elsevier, Amsterdam, 1055 p. 1998.
KWON-CHUNG, K.J. & BENNETT, J.E. - Cryptococcosis. In: KWON-CHUNG, K.J. & BENNETT, J.E. Med Mycol. Philadelphia, Lea & Febiger, p. 397-446. 1992.
mating types and virulence in Cryptococcus neoformans. Infect Immun., v. 60, n.2, p. 602-5.1992.
KWON-CHUNG, KJ, VARMA, A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res; v.6,p.574- 87. 2006.
LACAZ, C. S.; PORTO, E.; MARTINS, J.E.C.; HEINS, E.M.V.; MELO, N.T. Criptococose. In: Tratado de Micologia Médica. 9ª Edição: Ed. Savier;p.416-35. 2002.
LAZERA, M. S.; CAVALCANTI, M. A.; TRILLES, L.; NISHIKAWA, M. M.; WANKE, B.
Cryptococcus neoformans var. gattii - evidence for a natural habitat related to
decaying wood in a pottery tree hollow. Med Mycol, v.36, p.119-122, 1998.
LAZERA, M.S.; SALMITO-CAVALCANTI, M.A.; LONDERO, A.T.; TRILLES, L.; NISHIKAWA, M.M.; WANKE, B. Possible primary ecological niche of Cryptococcus
neoformans. Med Mycol v.38,p.379 -383, 2000.
LAZERA, M.S.; GUTIERREZ-GALHARDO, M.C.; CAVALCANTE, M.A.S.; WANKE, B. Criptococose. In JR Coura (org), Din Infec Parasit, v. II, 1ª ed., Guanabara Koogam, Rio de Janeiro, p. 1223-1235.2005.
LAGROU, K.; VAN ELDERE, J.; KEULEERS, S.; HAGEN, F.; MERCKX, R.;VERHAEGEN, J.; PEETERMANS, W.E.; BOEKHOUT, T. Zoonotic transmission of
Cryptococcus neoformans from a magpie to an immunocompetent patient. J Internal
Med, v.257, p.385-8, 2005.
LENGELER, K.B.; COX, G.M.; HEITMAN, J. Serotype AD strains of Cryptococcus
neoformans are diploid or aneuploid and are heterozygous at the mating-type
LENGELER, K.B., FOX, D.S., et al. Mating-type locus of Cryptococcus neoformans:a step in the evolution of sex chromosomes. Eukaryot Cell v.1 (5), p.704–718.2002. LIN, X.; HEITMAN J. The biology of the Cryptococcus neoformans species complex.
Annu Rev Microbiol; v.60,p.69–105. 2006.
LIN,X. Cryptococcus neoformans: Morphogenesis, infection and evolution. Infection, Genetics and Evolution v.9,p. 401-416.Elsevier.2009.
LINDENBERG, Andrea De Siqueira Campos. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop S. Paulo, São Paulo, v. 50, n. 2, 2008.
LIU, O.W.; CHUN,C.D.; CHOW, E.D.; CHEN, C.; MADHANI, H.D.; NOBLE, S.M. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus
neoformans. Cell. v.3; 135(1),p. 174–188.2008
LIZARAZZO, J, LINARES, M, de BEDOUT, C, RESTREPO, A, AGUDELO, CI, CASTAÑEDA, E. Estúdio clínico y epidemiológico de la criptococosis em Colômbia: resultados de nueve años de la encuesta nacional, 1997-2005. Biomédica. v.27,p.1- 16.2007
LORD, A.T.K.; MOHANDAS,K.; SOMANATH,S.; AMBU,S. Multidrug resistant yeasts in synanthropic wild birds. Annals of Clinical Microbiology and Antimicrobials, v.9,p.11.2010.
LUGARINE, C. Isolamento de Cryptococcus neoformans a partir de excretas de
Passeriformes e Psittaciformes no estado do Paraná. Dissertação. Universidade
Federal do Paraná. Pós Graduação em Ciências Veterinárias, Setor de Ciências Agrárias. Curitiba 2007.
var.neoformans isolado do solo., Rev Soc Bras Med Trop.São Paulo. v.35, n.1, p.77-9,1993.
MAGLIANI, W.; CONTI, S.; ARSENI, S.; SALATI, A.; RAVANETTI, L.; MAFFEI, D.L.; GIOVATI, L.; POLONELLI, L. Antibody-mediated protective immunity in fungal infections. New Microbiol v.28,p.299-309, 2005.
MARTINS, M.A. Análise molecular de isolados seriados de C. neoformans na
criptococose: recidiva ou re-infecção? Dissertação. Secretaria da Saúde.
Coordenadoria de Controle de Doenças. São Paulo; 83 p.2006.
MARTINS, M.A, PAPPALARDO, M.C.S.M, MELHEM, M.S.C., PEREIRA- CHIOCCOLA, V.L. Molecular diversity of serial Cryptococcus neoformans isolates from AIDS patients in the city of São Paulo, Brazil. Mem Inst Oswaldo Cruz v.102,p. 777–84.2007.
McCLELLAND, C. M.; CHANG, Y. C.; VARMA, A.; KWON-CHUNG, K. J. Uniqueness of the mating system in Cryptococcus neoformans. Trends Microbiol.v.12, n.5, p.208-12.2004.
MEYER, W.; MARSZEWSKA, K.; AMIRMOSTOFIAN, M. - Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis, v.20,p.1790-1799, 1999.
MEYER W.; CASTAÑEDA, A.; JACKSON, S. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gatii in Brazil. Mem Inst Oswaldo
MILAN, E. P.; ZAROR, L. Leveduras: identificação laboratorial. In: SIDRIM, J. J. C.; ROCHA, M. F. G. Micologia médica à luz de autores contemporâneos. Rio de Janeiro: Guanabara Koogan, cap. 6, p. 50 - 62.2004.
MINISTÉRIO DA SAÚDE. Dados e pesquisa em DST e AIDS. Coordenação do Programa Nacional de DST ⁄ AIDS. Brasília, DF. Disponível em: <http://www.aids.gov.br>.2005. Acesso em 10/01/2010.
MINISTÉRIO DA SAÚDE. Programa Nacional de DST e Aids. Boletim epidemiológico. Dados Epidemiológicos-aids, Brasília, DF, Brasil. Disponível em:
<http:www.aids.gov.br>. 2009. Acesso em 10/01/2010.
MINISTÉRIO DA SAÚDE - Dados e pesquisas em DST e Aids. Coordenação do programa nacional de DTS/Aids. Brasília, 2004. Disponível em: <http: www.aids.gov.br>. Acessado em: 23 de setembro de 2009.
MITCHELL, T.G, PERFECT, J.R. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev v.8(4),p.515-48. 1995.
MONARI, C.; BISTONI, F.; VECCHIARELLI, A. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. v.6,p.537–542.2006.
MONTENEGRO, H.; PAULA, C.R. Environmental isolation of Cryptococcus
neoformans var. gattii and C. neoformans var. neoformans in the city of São Paulo,
Brazil. Med Mycol v.38,p.385-390, 2000.
MOREIRA, T.A.; FERREIRA, M.S.; RIBAS, R.M.; BORGES, A.S. Criptococose: estudo clínico-epidemiológico, laboratorial e das variedades do fungo em 96 pacientes. Rev Soc Bras Med Trop. v.39,p. 255-258, 2006.
YASUDA,M.A. Guidelines in cryptococcosis – 2008. Rev Soc Bras Med
Trop.v.41,p.524-544.2008.
MORETTI-BRANCHINI, M.L.; TELLES, Filho F.Q. Criptococose. In: Condutas em
Infectologia. São Paulo; Atheneu. p. 367-375.2004.
MORSCHHAUSER,J. Regulation of multidrug resistance in pathogenic fungi. Fungal
Genet Biol.2009.
NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS (NCCLS).
Reference method for broth dilution antifungal susceptibility testing of yeasts.
Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA. 2002.
NEUVILLE, S, DROMER F, MORIN O. Primary cutaneous cryptococcosis: a distint clinical entidy. Clin Infect Dis v.36,p.337-47.2003.
NIELSEN, K.; HEITMAN, J. Sex and virulence of human pathogenic fungi. Adv
Genet. v.57,p.143–173.2007.
NIGRO, N.T.M.R.C.; PEREIRA, A.D.; HUGGINS, D.W.; LACAZ, C.S. Isolamento de
Cryptococcus neoformans de fezes de pombos, do solo e ninhos de pombos. Rev
Bras Med, v.44, n.1 e 2, p.6-9, 1987.
NISHIKAWA, M.M.; LAZERA, M.S.; BARBOSA,G.G.; TRILLES, L.; BALASSIANO, B.R.; MACEDO, R.C.L.; BEZERRA, C.C. F.; PEREZ, M.A.; CARDARELLI, P.; WANKE, B. Serotyping of 467 Cryptococcus neoformans Isolates from Clinical and Environmental Sources in Brazil: Analysis of Host and Regional Patterns.J Clin
NOCERA, V.B.; RONCHI JR, I.; PIETROVICZ,J.; KREBS, C. N. V; LOPES, G. L. Osteomielite criptocócica em paciente com mieloma múltiplo. Rev Bras Hematol
Hemoter; v.32(3),p. 265-268, 2010.
OHKUSU, M.; TANGONAN, N.; TAKEO, K. Serotyping, mating type and ploidy of
Cryptococcus neoformans strains isolated from patients in Brazil. Rev Inst Med
Trop. S. Paulo, v.44,p.299-302, 2002.
PAPPALARDO, M.C.S.M. Criptococose em Aids: estudo clínico e
microbiológico em 35 pacientes acompanhados no “Instituto de Infectologia Emílio Ribas”, São Paulo, entre 1995 a 1997. Dissertação. São Paulo:
Coordenação dos Institutos de Pesquisa da Secretaria de Estado da Saúde de São Paulo; 2003.
PAPPALARDO, M.C.S.M.; MELHEM,M.S.C. Criptococose: revisão sobre a experiência brasileira sobre a doença. Rev Inst Med Trop. S. Paulo, v. 45, n. 6, p. 299-305. 2003.
PAPPALARDO, M.C.S.M.; PASCHOAL, R.C.; MELHEM, M.S.C. AIDS-associated central nervous system cryptococcosis: a Brazilian case study. AIDS. v.21,p.1971- 1983, 2007.
PAPPALARDO, M.C.S.M. Parâmetros farmacocinéticos e farmacodinâmicos da
anfotericina B e fluconazol e sua contribuição no estudo da correlação clínico- laboratorial da criptococose de sistema nervoso central associada à AIDS.
Tese. São Paulo: Coordenadoria de Controle de Doenças da Secretaria de Estado da Saúde de São Paulo.2009.
PASQUALOTTO, AC, SEVERO, CB, OLIVEIRA, FM, SEVERO, LC. Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol; v.21,p.143-6. 2004.
neoformans isolated from human dwellings in Rio de Janeiro, Brazil: an analysis of
the domestic environment of AIDS patients with and without cryptococcosis. Med
Mycol v.36,p. 305-311.1998.
PEDROSO, R.S.; FERREIRA, J.C.; CANDIDO, R.C. In vitro susceptibility to to antifungal agents of environmental Cryptococcus spp isolated in the city of Ribeirão Preto, São Paulo, Brazil. Mem Inst Oswaldo Cruz., v. 105, p. 239-243, 2006.
PEREA, S.; PATTERSON, T.F. Antifungal resistance in pathogenic fungi.
Antimicrobial Resist.v.15,p.1073-1080.2002.
PERFECT, J.R.; CASADEVALL, A. Cryptococcosis. Infec Dis Clin North American.v.16,p.837-874, 2002.
PERKINS, A, GOMEZ-LOPEZ, A, MELLADO, E, RODRIGUEZ-TUDELA, JL, CUENCA-ESTRLLA, M. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrobial Chem; v.56,p. 1144-7. 2005.
PFALLER, M.A.; MESSER, S.A; BOYKEN, L.; RICE, C.; TENDOLKAR, S.; HOLLIS, R.J.; DOERN, G.V.; DIEKEMA, D.J. Global Trends in the Antifungal Susceptibility of
Cryptococcus neoformans (1990 to 2004). J Clin Microbiol., v. 43, p. 2163-2167,
2005.
PFALLER,M.A.; DIEKEMA, D. J.; GIBBS,D.L.; NEWELL,V.A.; BIJIE,H.; DZIERZANOWSKA,D.; KLIMKO,N.N.; LETSCHER-BRU,V.;LISANOVA,M.; MUEHLETHALER,K.; RENNISON,C.; ZAIDI,M; and the Global Antifungal Surveillance Group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing., J. Clin. Microbiol. v. 47 p. 117–123, n. 1.2009.
PINTO JUNIOR, V. L.; GALHARDO, M. C. G.; LAZERA, M.; WANKE, B.; REIS, R. S.; PEREZ M. Criptococose associada à AIDS. A importância do cultivo da urina no seu diagnóstico. Rev Soc Bras Med Trop.v. 39 (2),p. 230-232, 2006.
PRADO,M.; DA SILVA,M.B.; LAURENTI,R.; TRAVASSOS,L.R.; TABORDA,C.P. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996-2006. Mem Inst Osvaldo Cruz, v.104, p.513- 521.2009.
QUINTERO,E.;CASTAÑEDA,E.;RUIZ,A. Environmental distribution of Cryptococcus
neoformans in the department of Cundinamarca-Colombia. Rev Iberoam
Micol.v.12,p.56-60.2005.
RANDHAWA,H.S.;KOWSHIK,T.;KHAN,Z.U. Decayed wood of Syzygium cumini and
Ficus religiosa living trees in Delhi/New Delhi metropolitan area as natural habitat of Cryptococcus neoformans.Med Mycol.v.41,p.199-209.2003.
REIS-FILHO, J. B.; NEVES,A. C.; ZYMBERG, S. T. ; OLIVEIRA, R.M.C. - O líquido cefalorraquiano inicial nas meningoencefalites por Cryptococcus neoformans. Rev
Inst Med Trop. S. Paulo, Review. v. 27, p. 173-178, 1985.
REOLON, A.; PEREZ, L.R.R.; MEZZARL, A. Prevalência de Cryptococcus